Palisade Bio Files 8-K on Security Holder Votes
Ticker: PALI · Form: 8-K · Filed: Oct 20, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Oct 20, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
Related Tickers: PALI
TL;DR
Palisade Bio (PALI) filed an 8-K for shareholder votes as of Oct 17. Watch for updates.
AI Summary
Palisade Bio, Inc. filed an 8-K on October 20, 2025, reporting on matters submitted to a vote of its security holders as of October 17, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). It also lists former company names, Seneca Biopharma, Inc. and Neuralstem, Inc., with their respective name change dates.
Why It Matters
This filing indicates that Palisade Bio, Inc. is engaging in corporate actions requiring shareholder approval, which could impact the company's strategic direction and future operations.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing a vote of security holders, not an event that inherently introduces new financial or operational risks.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- October 17, 2025 (date) — Date of earliest event reported
- October 20, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Seneca Biopharma, Inc. (company) — Former Company Name
- Neuralstem, Inc. (company) — Former Company Name
FAQ
What specific matters were submitted to a vote of Palisade Bio, Inc.'s security holders?
The filing does not specify the exact matters submitted for a vote, only that it is a 'Submission of Matters to a Vote of Security Holders'.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated October 17, 2025.
What is Palisade Bio, Inc.'s principal executive office address?
The principal executive offices are located at 1902 Wright Place, Suite 200, Carlsbad, California, 92008.
What was Palisade Bio, Inc. formerly known as?
Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. and prior to that, Neuralstem, Inc.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Stats: 733 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-10-20 17:22:00
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 50KB
- 0001493152-25-018684.txt ( ) — 213KB
- pali-20251017.xsd (EX-101.SCH) — 3KB
- pali-20251017_lab.xml (EX-101.LAB) — 33KB
- pali-20251017_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 20, 2025 Palisade Bio, Inc. By: /s/ J.D. Finley J.D. Finley Chief Executive Officer